First Trust Advisors LP grew its holdings in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 60.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,335 shares of the company's stock after acquiring an additional 6,874 shares during the period. First Trust Advisors LP owned about 0.27% of Nutex Health worth $1,743,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also made changes to their positions in NUTX. Hussman Strategic Advisors Inc. bought a new stake in Nutex Health during the 4th quarter valued at approximately $3,457,000. SG Americas Securities LLC boosted its stake in Nutex Health by 3,232.6% in the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company's stock worth $2,885,000 after purchasing an additional 29,449 shares during the period. Allspring Global Investments Holdings LLC bought a new position in Nutex Health in the 1st quarter worth approximately $360,000. Bank of America Corp DE grew its holdings in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares in the last quarter. Finally, Royal Bank of Canada grew its holdings in Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company's stock valued at $59,000 after buying an additional 316 shares in the last quarter. 5.32% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
NUTX has been the topic of several recent analyst reports. B. Riley Financial initiated coverage on shares of Nutex Health in a research report on Friday, June 26th. They set a "buy" rating and a $290.00 price objective on the stock. Zacks Research raised shares of Nutex Health to a "hold" rating in a research note on Monday, June 29th. Weiss Ratings upgraded shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, July 28th. Lake Street Capital assumed coverage on shares of Nutex Health in a research note on Tuesday, June 2nd. They issued a "buy" rating and a $235.00 price target on the stock. Finally, Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Monday, July 20th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Nutex Health currently has a consensus rating of "Moderate Buy" and an average target price of $243.33.
Read Our Latest Analysis on Nutex Health
Nutex Health Stock Performance
NASDAQ:NUTX opened at $162.07 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. Nutex Health Inc. has a 1 year low of $77.21 and a 1 year high of $204.00. The stock's 50 day simple moving average is $157.23 and its two-hundred day simple moving average is $129.20. The company has a market cap of $1.12 billion, a price-to-earnings ratio of 6.36 and a beta of 0.24.
Nutex Health Company Profile
(
Free Report)
Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
